Key Metrics
Factor Lens
Seasonal Performance
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Bio-Rad Laboratories, Inc. is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems,… reagents, and consumables. The company operates in two industry segments: Life Science and Clinical Diagnostics. The Life Science segment develops instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials including cells, proteins, and nucleic acids for research, biopharmaceutical laboratory environments, biopharmaceutical manufacturing, quality control processes, food safety testing, and science education applications. The Clinical Diagnostics segment designs and manufactures diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories, offering more than 300 in vitro diagnostic tests. Bio-Rad has direct operations in over 36 countries, with approximately 40% of revenues from the U.S. and 60% from international locations, with Europe being the largest international region. The company estimates worldwide sales in Life Science markets to be approximately $19 billion and in Clinical Diagnostics markets to be approximately $16 billion.
- Name
- Bio-Rad Laboratories, Inc.
- Sector
- Technology
- Industry
- Technology
- CEO
- Norman Schwartz · Chief Executive Officer and Chairman of the Board
- Employees
- 7,450 as of 2025-12-31
- IPO Date
- 2011-06-15
- Phone
- (510) 724-7000
- Address
- 1000 Alfred Nobel Drive, Hercules, CA 94547
- Website
- www.bio-rad.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Arnold A. Pinkston | Director | — |
| Melinda Litherland | Director | — |
| Gregory K. Hinckley | Director | — |
| Jeffrey L. Edwards | Director | — |
| Norman Schwartz | Chief Executive Officer and Chairman of the Board | — |
Latest News
- 2026-04-23
- 2026-04-22
- 2026-04-16
-
2026-04-16
Longleaf Partners Global Fund Q1 2026 Portfolio Review seekingalpha.com
-
2026-04-15
Analyzing Bio-Rad Laboratories (NYSE:BIO) & Haemonetics (NYSE:HAE) defenseworld.net
- 2026-04-14
- 2026-04-07
- 2026-04-03